Skip to content

Drug interactions

Mefloquine + Repotrectinib

Severity: Moderate

Mefloquine and Repotrectinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mefloquine inhibits P-glycoprotein and may increase repotrectinib exposure, which could increase its neurological and other adverse effects. The effect is predicted rather than well characterised clinically.

What this interaction means in plain words

Mefloquine and Repotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mefloquine belongs to Anti Parasitic; Repotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of P-gp efflux of repotrectinib by mefloquine.

What to do

Monitor for repotrectinib toxicity such as dizziness, ataxia and cognitive effects. Consider an alternative antimalarial if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mefloquine and Repotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mefloquine with Repotrectinib?

MediHelp rates the interaction as moderate. Mefloquine and Repotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Mefloquine inhibits P-glycoprotein and may increase repotrectinib exposure, which could increase its neurological and other adverse effects. The effect is predicted rather than well characterised clinically.

How serious is the interaction between Mefloquine and Repotrectinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for repotrectinib toxicity such as dizziness, ataxia and cognitive effects. Consider an alternative antimalarial if toxicity develops.

What other medicines interact with Mefloquine?

MediHelp also lists interactions of Mefloquine with, for example, Arsenic trioxide, Dronedarone, Ibutilide. The full list is on the Mefloquine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in